EGFR (epidermal growth factor receptor) amplification, for instance, is a marker for gefitinib treatment [1] and TYMS (thymidylate synthase) amplification conveys 5-fluorouracil resistance in colon tumors [2]. The gene discussed is EGFR; the disease is colonic neoplasm.